Yeast Genetics and Molecular Biology 2002
University of Wisconsin
Madison, Wisconsin USA
July 30 - August 4, 2002


Name: Hanes, Steven D.
Mailing Address: Dept. of Biomedical Sciences, Wadsworth Center/SUNY-Albany, 120 New Scotland Ave, Albany, NY 12208, USA
Email Address: hanes@wadsworth.org
Phone & FAX numbers: 518 473-4213

Abstract #46


Session Title: Transcription, Elongation and Termination
Session Time: Friday, August 2 -- 11:00AM - 12:30PM
Presentation: Platform
Topic: Gene Expression

A genetic model for control of RNA polymerase II function by Ess1-mediated isomerization of the C-terminal domain (CTD).
Steven D. Hanes, Xiaoyun Wu, Cathy B. Wilcox, Gina Devasahayam, Vishnu Chaturvedi
Dept. of Biomedical Sciences, Wadsworth Center/SUNY-Albany, 120 New Scotland Ave, Albany, NY 12208, USA

Ess1, is an essential prolyl-isomerase in S. cerevisiae that is conserved from yeast to humans. Ess1 recognizes phospho-Ser-Pro motifs and binds to the CTD of Rpb1, the large subunit of RNA pol II. The CTD consists of 26 YSPTSPS repeats, and is thought to act as a landing-pad for protein complexes (e.g. initiation, elongation, termination, 3' end formation, splicing) required for ordered transcription. A major question is how the binding of these complexes is coordinated in a stepwise fashion. The CTD undergoes reversible phosphorylation. This is one mechanism by which protein binding might be regulated. A second mechanism might also be important; conformational isomerization of the CTD by Ess1. Consistent with such a model, we showed physical and genetic interactions between Ess1 and Rpb1, and identified high-copy suppressors of ess1-ts mutants that include RNA pol II subunits and cofactors. Ess1 acts positively on RNA pol II, opposing the action of the Rsp5 ubiquitin-ligase, which also binds the CTD. ESS1 also shows genetic interactions with genes encoding 3 CTD kinases, KIN28, CTK1 and SRB10. The interactions suggest that Ess1 acts at multiple steps in transcription, stimulating PIC formation and promoter release, and later blocking elongation, allowing termination and 3' end formation to occur. Finally, ESS1 was cloned from C. albicans and shown to be essential for growth and morphogenetic switching, suggesting that it might be a useful antifungal drug target.


Return to YGM 2002 Home at SGD